Stuart Siedman

COTA and the FDA will advance #cancerresearch using #realworlddata, focusing on #regulatory decision-making and improving treatment evaluation and availability. Read at The Evidence Base® #heor #healtheconomics #outcomesresearch #rwe #rwd #realworldevidence #pharma #biopharma #medicalaffairs #regulation #regulatoryaffairs #healthdata

25

Join us in Boston August 20th for a featured panel on Balancing and Implementing Right and Downsizing Strategies at The Bioprocessing Summit's 2nd annual Talent in Biopharma Leadership Workshop! Our panelists will discuss how navigating change in biotechs involves predicting trends, defining right-sizing versus downsizing, and pre-planning for outcomes. Companies must balance retention and termination packages during workforce adjustments, while leaders should plan for team changes, including their own roles. After changes, maintaining company culture is crucial. By addressing these aspects strategically, biotechs can adapt to challenges and emerge stronger while supporting their employees through transitions. Save 20% on your registration with code TALENT20. Seats are almost full. Reserve your spot via: https://lnkd.in/eqszVKMd  #CHIBioprocessingSummit #WorkforceManagement #CompanyCulture #ChangeManagement Mike Gamble Patrick Lucy Jay Blackington Ted Harding Adam Thomas (he/him)

5

QurAlis' CSO Dan Elbaum and Sandy Hinckley, vp and head of discovery, took the #ALSIceBucketChallenge at the #ALSNexus conference to help continue to raise awareness and support for ALS research with the goal of discovering and developing new treatments and ultimately a cure. #icebucket10 #precisionmedicine #neurodegenerativediseases #neurologicaldiseases

78

1 Comment

The Chamber of Commerce for Greater Philadelphia released “Leading the Way: Cell and Gene Therapy in Greater Philadelphia Sector Snapshot 2024." This in-depth report describes the Greater Philadelphia region’s remarkable growth journey in the cell and gene therapy (CGT) sector over the past decade, showcases how Greater Philadelphia has emerged as a global leader in CGT and highlights a variety of Penn’s contributions to the field. The report notes that Penn has spun out 40 companies since 2018, which has significantly contributed to the growth of the CGT sector in Greater Philadelphia. In addition, Penn Medicine was recognized as a top location for Phase I and II trials in novel cell and gene therapies and the Penn mRNA Institute recently received a $350 million investment. All of this has helped further grow the expanding CGT space in Philadelphia, which has received over $8 billion in private capital invested since 2018 and generated 7,000 jobs. Read the full report here: https://lnkd.in/g-UKX6Rc 

21

Here are the details！

1

The Young Lung Cancer Initiative has announced the release of Episode 1 of their YLCI Podcast: Patient Education Series. This episode, focused on "Misconceptions of Clinical Trials," is a collaboration with EGFR Resisters and is sponsored by Black Diamond Therapeutics. https://lnkd.in/eemiW3NW #OncoDaily #Oncology #Cancer #Health #Medicine #ClinicalTrials

29